JAK2 and atypical chronic myeloid leukemia, BCR-ABL1 negative: On the other hand, the absence of rearrangements involving PDGFRA or PDGFRB (3) and FGFR1 (1) and the negativity for JAK2 V617F mutation (64) all support a diagnosis of aCML.